Lilly sues four telehealth firms for unauthorized compounding of Mounjaro and Zepbound. 2. GLP 1 drugs remain in high demand ...

A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...

Eli Lilly (LLY) is among the list of large-cap ... be enough to weaken the threat of tariffs on the sector. "Declare victory and move on [would] be my advice," he said. Anjalee Khemlani is the ...

Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...

Eli Lilly and Co. broke ground Tuesday on its $4.5 billion Lilly Medicine Foundry, praising the campus as a new model for drug development. The Indianapolis-based drugmaker said the Lilly Medicine ...

Eli Lilly (LLY) is among the list of large-cap pharmaceutical companies ... stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any ...